Breaking News Instant updates and real-time market news.

RHHBY

Roche

$30.70

-0.26 (-0.84%)

07:13
10/05/16
10/05
07:13
10/05/16
07:13

Genentech granted Breakthrough Therapy Designation status for Actemra for GCA

Genentech, a member of the Roche Group, announced today that the FDA has granted Breakthrough Therapy Designation status to Actemra for giant cell arteritis, or GCA, a chronic, potentially life-threatening autoimmune condition. The disease is caused by inflammation of large and medium-sized arteries, most often in the head, but also in the aorta and its branches.

  • 19

    Oct

  • 06

    Nov

  • 10

    Nov

RHHBY Roche
$30.70

-0.26 (-0.84%)

09/01/16
BMOC
09/01/16
NO CHANGE
BMOC
Bristol-Myers has negative read through from Roche data, says BMO Capital
BMO Capital analyst Alex Arfaei says that the positive data on Roche's (RHHBY) TECENTRIQ for second line NSCLC is negative for Bristol-Myers' (BMY) cancer drug, Opdivo. The analyst does not think that TECENTRIQ's results will be superior to that of Opdivo, but he believes that Roche's drug appears to have "a significant" benefit in PD-L1 positive patients." He predicts that Roche's drug could take "meaningful market share, particularly outside of the U.S." The analyst keeps a Market Perform rating on Bristol-Myers.
09/07/16
09/07/16
NO CHANGE

BioLineRx partnering with Roche company in cancer therapy research
BioLineRx (BLRX) has entered into a collaboration with Genentech, a member of the Roche (RHHBY) Group, to support several Phase 1b studies investigating BioLineRx's BL-8040 in combination with Atezolizumab, Genentech's anti-PDL1 cancer immunotherapy, in multiple cancer indications. The Phase 1b studies will evaluate the clinical response, safety and tolerability of the combination of these therapies, as well as multiple pharmacodynamic parameters, in hematologic malignancies and solid tumors. Under the agreement, Genentech will sponsor and conduct several Phase 1b trials in multiple solid cancer indications. In addition, BioLineRx will sponsor and conduct a Phase 1b study in acute myeloid leukemia patients. The studies are designed to evaluate the safety and efficacy of the combination of BL-8040 and Atezolizumab. Upon completion of the studies, both parties will have the option to expand the collaboration to include a pivotal registration study. Additional details of the collaboration were not disclosed.
09/12/16
JEFF
09/12/16
NO CHANGE
Target $57
JEFF
Hold
Jefferies cuts Bristol-Myers price target, upgrades AstraZeneca
Jefferies analyst Jeffrey Holford lowered his price target for Bristol-Myers Squibb (BMY) to $57 from $69 saying the stock is positioned for a "rough mid term ride." The analyst sees a "difficult catalyst" set for Bristol shares with "numerous" upcoming competitor read-outs in non-small cell lung cancer. The market could see worse than expected data from Bristol's CM-026 and CM-568 studies as well as better than expected data from AstraZeneca's (AZN) MYSTIC study and Roche's (RHHBY) Chemo-IO studies in the first half of 2017, Holford tells investors in a research note. He keeps a Hold rating on Bristol and upgraded this morning AstraZeneca to Buy from Hold. Holford prefers Astra for its immunology exposure.
09/27/16
PIPR
09/27/16
NO CHANGE
Target $62
PIPR
Neutral
Bristol-Myers price target lowered to $62 from $65 at Piper Jaffray
Piper Jaffray analyst Richard Purkiss lowered his price target for Bristol-Myers Squibb (BMY) to $62 saying he sees the company ceding Opdivo's early-mover advantage in lung cancer to competitors. The analyst expects to see details from Roche's (RHHBY) positive OAK trial of Tecentriq vs. docetaxel in non-small cell lung cancer at the upcoming ESMO meeting. Purkiss also expects to see details from Merck's (MRK) positive KEYNOTE-024 trial of Keytruda. The analyst lowered his post-2016 Opdivo forecasts and reiterates a Neutral rating on Bristol shares.

TODAY'S FREE FLY STORIES

DFIN

Donnelley Financial Solutions

$21.66

-0.41 (-1.86%)

06:27
06/23/17
06/23
06:27
06/23/17
06:27
Initiation
Donnelley Financial Solutions initiated  »

Donnelley Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$57.64

-0.41 (-0.71%)

06:24
06/23/17
06/23
06:24
06/23/17
06:24
Upgrade
Prologis rating change  »

Prologis upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRE

Duke Realty

$28.28

-0.22 (-0.77%)

06:24
06/23/17
06/23
06:24
06/23/17
06:24
Downgrade
Duke Realty rating change  »

Duke Realty downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

, WFM

Whole Foods

$43.20

-0.06 (-0.14%)

06:23
06/23/17
06/23
06:23
06/23/17
06:23
Periodicals
Some believe Whole Foods would give Amazon 'unfair advantage,' Reuters says »

Antitrust experts believe…

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

WFM

Whole Foods

$43.20

-0.06 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

06:21
06/23/17
06/23
06:21
06/23/17
06:21
Technical Analysis
Technical View: Bed Bath & Beyond tumbles after earnings miss expectations »

The company reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

NAP

Navios Maritime Midstream

$9.88

0.13 (1.33%)

06:19
06/23/17
06/23
06:19
06/23/17
06:19
Downgrade
Navios Maritime Midstream rating change  »

Navios Maritime Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$957.09

-2.36 (-0.25%)

, GOOGL

Alphabet Class A

$976.62

-1.97 (-0.20%)

06:19
06/23/17
06/23
06:19
06/23/17
06:19
Periodicals
Waymo hires former Tesla engineer to lead hardware team, Bloomberg says »

Alphabet's (GOOG,…

GOOG

Alphabet

$957.09

-2.36 (-0.25%)

GOOGL

Alphabet Class A

$976.62

-1.97 (-0.20%)

TSLA

Tesla

$382.61

6.21 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

  • 02

    Oct

TSN

Tyson Foods

$61.72

0.34 (0.55%)

06:16
06/23/17
06/23
06:16
06/23/17
06:16
Hot Stocks
Tyson Foods to invest $49M to expand Macon, GA distribution center »

Tyson Foods, Inc. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$32.66

-0.5 (-1.51%)

06:15
06/23/17
06/23
06:15
06/23/17
06:15
Downgrade
Hain Celestial rating change  »

Hain Celestial downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

BA

Boeing

$199.44

0.27 (0.14%)

, EADSY

Airbus

$20.80

-0.07 (-0.34%)

06:14
06/23/17
06/23
06:14
06/23/17
06:14
Periodicals
Boeing announces layoffs at 787 Dreamliner campus, Post and Courier says »

Boeing (BA) is cutting…

BA

Boeing

$199.44

0.27 (0.14%)

EADSY

Airbus

$20.80

-0.07 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.40

-0.51 (-0.33%)

, MSFT

Microsoft

$70.26

-0.01 (-0.01%)

06:12
06/23/17
06/23
06:12
06/23/17
06:12
Periodicals
LinkedIn CEO: Sandberg seems 'quite happy' at Facebook, NY Post reports »

Jeff Weiner, the CEO of…

FB

Facebook

$153.40

-0.51 (-0.33%)

MSFT

Microsoft

$70.26

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

  • 20

    Jul

SKT

Tanger Factory

$25.70

0.48 (1.90%)

06:11
06/23/17
06/23
06:11
06/23/17
06:11
Downgrade
Tanger Factory rating change  »

Tanger Factory downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$20.80

-0.07 (-0.34%)

06:09
06/23/17
06/23
06:09
06/23/17
06:09
Periodicals
Airbus' sales chief Leahy may retire before Dubai Airshow, Reuters reports »

John Leahy, Airbus'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

, TWTR

Twitter

$18.15

0.37 (2.08%)

06:07
06/23/17
06/23
06:07
06/23/17
06:07
Periodicals
Amazon wants to sell Thurs. Night Football ad deals for $2.8M each, Reuters says »

Amazon (AMZN) wants to…

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

TWTR

Twitter

$18.15

0.37 (2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

F

Ford

$11.13

0.09 (0.82%)

06:05
06/23/17
06/23
06:05
06/23/17
06:05
Periodicals
Ford recalling nearly 16,000 cars in South Africa due to fire risk, Reuters says »

Ford is recalling almost…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

ENOC

EnerNOC

$7.65

2.25 (41.67%)

06:05
06/23/17
06/23
06:05
06/23/17
06:05
Downgrade
EnerNOC rating change  »

EnerNOC downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$154.40

0.61 (0.40%)

06:05
06/23/17
06/23
06:05
06/23/17
06:05
Hot Stocks
IBM achieves climate protection goals four years early »

IBM announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVHY

Vivendi

$22.76

-0.105 (-0.46%)

06:04
06/23/17
06/23
06:04
06/23/17
06:04
Upgrade
Vivendi rating change  »

Vivendi upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$103.84

0.37 (0.36%)

06:04
06/23/17
06/23
06:04
06/23/17
06:04
Downgrade
Caterpillar rating change  »

Caterpillar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$104.22

-0.58 (-0.55%)

, GOOG

Alphabet

$957.09

-2.36 (-0.25%)

05:59
06/23/17
06/23
05:59
06/23/17
05:59
Periodicals
Spotify names Staggs, Warrior to board; Parker leaves board, TechCrunch says »

Spotify has appointed…

DIS

Disney

$104.22

-0.58 (-0.55%)

GOOG

Alphabet

$957.09

-2.36 (-0.25%)

GOOGL

Alphabet Class A

$976.62

-1.97 (-0.20%)

CSCO

Cisco

$31.85

0.01 (0.03%)

P

Pandora

$7.80

0.29 (3.86%)

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

AAPL

Apple

$145.63

-0.24 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 12

    Jul

  • 19

    Jul

  • 08

    Aug

  • 16

    Aug

SPX

S&P 500

05:55
06/23/17
06/23
05:55
06/23/17
05:55
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$86.34

3.78 (4.58%)

05:52
06/23/17
06/23
05:52
06/23/17
05:52
Hot Stocks
Novartis Kisqali receives CHMP opinion as first-line treatment for HR+/HER2- »

Novartis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

GDX

Market Vector Gold Miners

$22.36

0.25 (1.13%)

05:51
06/23/17
06/23
05:51
06/23/17
05:51
Technical Analysis
Market Vector Gold Miners: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$118.92

0.4 (0.34%)

05:50
06/23/17
06/23
05:50
06/23/17
05:50
Technical Analysis
SPDR Gold Trust: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$86.34

3.78 (4.58%)

05:50
06/23/17
06/23
05:50
06/23/17
05:50
Hot Stocks
Novartis: half of eligible patients remain in TFR nearly 2 years after Tasigna »

Novartis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.